The company said it completed the sale of its chemical business to Berkshire Hathaway on January 2, 2026 under the Purchase Agreement for $9.7 billion in cash, subject to customary purchase price adjustments.

1. 01

   The company said it completed the sale of its chemical business to Berkshire Hathaway on January 2, 2026 under the Purchase Agreement for $9.7 billion in cash, subject to customary purchase price adjustments.

2. 02

   The company explained that under the Purchase Agreement signed on October 1, 2025, Berkshire Hathaway agreed to acquire all of the issued and outstanding equity interests in Occidental Chemical Corporation, which holds its chemical business, in an all-cash transaction.

3. 03

   The company said its subsidiary Environmental Resource Holdings, LLC (ERH) retained OxyChem's legacy tort claims and environmental liabilities, primarily related to historical operations outside the footprint of the operating facilities that were sold. It said it expects to spend remediation funds over many years under approved workplans.

4. 04

   The company said it attached as Exhibit 99.2 unaudited pro forma condensed consolidated financial information reflecting the divestiture and certain debt redemption transactions. It includes a balance sheet as of September 30, 2025 and statements of operations for the 9 months ended September 30, 2025 and for the fiscal years 2024, 2023 and 2022.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.